Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

1

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

1 companies

Hypera

Market Cap: R$15.2b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$21.60

7D

1.6%

1Y

-6.9%